97 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

MEOB.F

Mesoblast
AU$0.610.9%n/aAU$1.0bn/aPS90.7xE56.8%n/a

BFRI

Biofrontera
US$1.59-5.9%-86.5%US$8.1mUS$16.00PB1.7xE65.8%n/a

PGEN

Precigen
US$1.416.0%16.5%US$351.0mUS$9.00PS56.4xE55.5%n/a

CRMD

CorMedix
US$5.310.6%7.5%US$291.9mUS$13.00PB4.2xE59.6%n/a

TBPH

Theravance Biopharma
US$9.12-2.4%-15.8%US$442.9mUS$15.40PS7.7xE61.4%n/a

GNFT

Genfit
€3.492.3%-12.8%€159.6m€10.20PS4.6xE54.7%n/a

MDWD

MediWound
US$18.2415.7%58.5%US$168.8mUS$28.50PS9xE56.3%n/a

VRCA

Verrica Pharmaceuticals
US$6.87-1.6%11.3%US$291.4mUS$13.60PS56.9xE61.6%n/a

SBFM

Sunshine Biopharma
US$0.95-46.2%-98.5%US$944.8kUS$300.00PB0.04xE134.4%n/a

ARGX

argenx
€372.803.5%-3.9%€20.7b€468.87PS17.5xE56.1%n/a

OCUP

Ocuphire Pharma
US$1.61-2.7%-68.6%US$39.9mUS$19.50PS2.1xE9.5%n/a

AMYT

Amryt Pharma
US$14.700.7%86.5%US$940.7mUS$20.75PS3.9xE53.9%n/a

KRTX

Karuna Therapeutics
US$329.833.3%80.7%US$12.6bUS$326.92PS19238.9xE60.1%n/a

GNFT.F

Genfit
€2.950%n/a€157.1m€8.62PS4.6xE54.7%n/a

GNNS.F

Genscript Biotech
HK$1.500%-41.4%HK$22.9bHK$4.02PS3.5xE92.5%0%

IOVA

Iovance Biotherapeutics
US$11.642.9%106.4%US$3.3bUS$26.00PS2734.3xE61.7%n/a

VCEL

Vericel
US$46.055.3%46.1%US$2.2bUS$53.90PS11.3xE49.3%n/a

MESO

Mesoblast
AU$6.2419.8%5.8%AU$1.1bAU$7.38PS92.9xE56.8%n/a

RYTM

Rhythm Pharmaceuticals
US$38.280.7%89.8%US$2.3bUS$57.33PS30.1xE60.8%n/a

LQDA

Liquidia
US$12.53-5.7%86.7%US$952.6mUS$23.86PS54.5xE59.6%n/a

CTXR

Citius Pharmaceuticals
US$0.66-11.9%-54.2%US$105.8mUS$4.00PB1.2xE62.7%n/a

CASI

CASI Pharmaceuticals
US$2.427.6%-15.4%US$31.4mUS$12.00PB1.3xE57.6%n/a

ARGN.F

argenx
€383.740%n/a€20.7b€482.63PS17.5xE56.1%n/a

ZYNE

Zynerba Pharmaceuticals
US$1.304.0%96.1%US$65.6mUS$1.26PB2.3xE67.2%n/a
Page 2 of 5
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.